Tag: divestiture advisory services

In the highly competitive and innovation-driven pharmaceutical industry, patents are among the most valuable assets for drug companies. These intellectual property rights provide the exclusive authority to manufacture and sell a drug, offering a critical competitive edge and a substantial return on investment in research and development (R&D). However, as the pharmaceutical landscape evolves—marked by […]